SAA1 and renal fibrosis: Consequently, this combination of SAA pro-inflammatory activity manifested as increased renal fibrosis that was focal to the external surface of Bowman’s capsule and distributed in a peritubular fashion (affecting both proximal and distil tubules) when assessed 16 weeks after the cessation of SAA administration.